SXI Life Sciences
7.542,66
PKT
+17,25
PKT
+0,23
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.06.22 | Novartis Sell | Deutsche Bank AG | |
| 22.06.22 | Novartis Neutral | UBS AG | |
| 22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.06.22 | Novartis Sell | Deutsche Bank AG | |
| 16.06.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.06.22 | Roche Hold | Deutsche Bank AG | |
| 07.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 27.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 26.05.22 | Roche Hold | Deutsche Bank AG | |
| 26.05.22 | Roche Outperform | Bernstein Research | |
| 19.05.22 | Roche Neutral | Credit Suisse Group | |
| 13.05.22 | Roche Hold | Jefferies & Company Inc. | |
| 12.05.22 | Roche Equal-weight | Morgan Stanley | |
| 12.05.22 | Roche Hold | Deutsche Bank AG | |
| 11.05.22 | Roche Outperform | Bernstein Research | |
| 11.05.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.05.22 | Roche Overweight | Barclays Capital | |
| 11.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.05.22 | Roche Sell | UBS AG | |
| 11.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | Novartis Neutral | Credit Suisse Group | |
| 27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.22 | Novartis Neutral | UBS AG | |
| 27.04.22 | Novartis Sell | Deutsche Bank AG | |
| 26.04.22 | Novartis Neutral | UBS AG | |
| 26.04.22 | Roche Neutral | Credit Suisse Group | |
| 26.04.22 | Roche Buy | Deutsche Bank AG | |
| 26.04.22 | Roche Overweight | Barclays Capital | |
| 26.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 26.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.04.22 | Roche Outperform | Bernstein Research | |
| 25.04.22 | Roche Sell | UBS AG |